Case of mononeuritis multiplex onset with rituximab therapy for Waldenström's macroglobulinemia

Journal of the Neurological Sciences

Volumn 260, Issue 1-2, 2007, Pages 240-243

  Mauermann, Michelle L ^a   Ryan, Matthew L ^a   Moon, Joon Shik ^a   Klein, Christopher J ^a  

^a Mayo Clinic   (United States)

Author keywords

Cryoglobulinemia; Mononeuritis multiplex; Neuropathy; Rituximab; Vasculitis; Waldenstr m's macroglobulinemia

Indexed keywords

CYCLOPHOSPHAMIDE; NARCOTIC AGENT; RITUXIMAB;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MONONEUROPATHY MULTIPLEX; NERVE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SURAL NERVE; SYMPTOM; SYSTEMIC VASCULITIS; WALDENSTROEM MACROGLOBULINEMIA;

AGED; ANTIBODIES, MONOCLONAL; CRYOGLOBULINEMIA; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MONONEUROPATHIES; PERIPHERAL NERVES; SURAL NERVE; TREATMENT OUTCOME; VASCULITIS; WALDENSTROM MACROGLOBULINEMIA;

EID: 34547657335     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.04.009     Document Type: Article

References (31)

1. Kelly J. Neurologic disorders in benign and malignant plasma cell dyscrasias (2004), Martin Dunitz, London
2. Ropper A.H., and Gorson K.C. Neuropathies associated with paraproteinemia. N Engl J Med 338 22 (1998) 1601-1607
3. Isobe T., and Osserman E.F. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann N Y Acad Sci 190 (1971) 507-518
4. Osby E., Noring L., Hast R., Kjellin K.G., Knutsson E., and Siden A. Benign monoclonal gammopathy and peripheral neuropathy. Br J Haematol 51 4 (1982) 531-539
5. Kelly Jr. J.J., Kyle R.A., O'Brien P.C., and Dyck P.J. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 31 11 (1981) 1480-1483
6. Suarez G.A., and Kelly Jr. J.J. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 43 7 (1993) 1304-1308
7. Gosselin S., Kyle R.A., and Dyck P.J. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 30 1 (1991) 54-61
8. Rojas-Garcia R., Gallardo E., de Andres I., de Luna N., Juarez C., Sanchez P., et al. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab. Neurology 61 12 (2003) 1814-1816
9. Renaud S., Gregor M., Fuhr P., Lorenz D., Deuschl G., Gratwohl A., et al. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27 5 (2003) 611-615
10. Broglio L., and Lauria G. Worsening after rituximab treatment in anti-mag neuropathy. Muscle Nerve 32 3 (2005) 378-379
11. Owen R.G., Treon S.P., Al-Katib A., Fonseca R., Greipp P.R., McMaster M.L., et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30 2 (2003) 110-115
12. Levine T., Pestronk A., Florence J., Al-Lozi M.T., Lopate G., Miller T., et al. Peripheral neuropathies in Waldenstrom's macroglobulinaemia. J Neurol Neurosurg Psychiatry 77 2 (2006) 224-228
13. Fraser D.M., Parker A.C., Amer S., and Campbell I.W. Mononeuritis multiplex in a patient with macroglobulinaemia. J Neurol Neurosurg Psychiatry 39 7 (1976) 711-715
14. Massey E.W., Pleet A.B., and Brannon W.L. Waldenstrom's macroglobulinemia and mononeuritis multiplex. Ann Intern Med 88 3 (1978) 360-361
15. Lamarca J., Casquero P., and Pou A. Mononeuritis multiplex in Waldenstrom's macroglobulinemia. Ann Neurol 22 2 (1987) 268-272
16. Tassin S., Ferriere G., and Laterre E.C. Mononeuritis multiplex in a case of primary macroglobulinemia (author's transl). Acta Neurol Belg 80 5 (1980) 287-297
17. Dimopoulos M.A., Kyle R.A., Anagnostopoulos A., and Treon S.P. Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol 23 7 (2005) 1564-1577
18. Klein C.M., and Suarez G. The natural history of peripheral neuropathy associated with cryoglobulinemia. Neurology 54 suppl 3 (2000) A385
19. Pekow J., and Chung R.T. Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab. J Clin Gastroenterol 40 5 (2006) 450
20. Ghobrial I.M., Uslan D.Z., Call T.G., Witzig T.E., and Gertz M.A. Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrom macroglobulinemia does not indicate failure of response. Am J Hematol 77 4 (2004) 329-330
21. Zaja F., De Vita S., Mazzaro C., Sacco S., Damiani D., De Marchi G., et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101 10 (2003) 3827-3834
22. Rosenthal E., Pesce A., Karsenti J.M., Allieri-Rosenthal M.A., and Cassuto J.P. Polyneuropathy and vasculitis associated with IgG type I cryoglobulinemia can be treated effectively with the anti-CD20 monoclonal antibody (rituximab). Blood 98 (2001) 292b [suppl]
23. Nehme-Schuster H., Korganow A.S., Pasquali J.L., and Martin T. Rituximab inefficiency during type I cryoglobulinaemia. Rheumatology (Oxford) 44 3 (2005) 410-411
24. Noronha V., Fynan T.M., and Duffy T. Flare in neuropathy following rituximab therapy for Waldenstrom's macroglobulinemia. J Clin Oncol 24 1 (2006) e3
25. Treon S.P., Branagan A.R., Hunter Z., Santos D., Tournhilac O., and Anderson K.C. Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia. Ann Oncol 15 10 (2004) 1481-1483
26. Onrust S.V., Lamb H.M., and Balfour J.A. Rituximab. Drugs 58 1 (1999) 79-88 [discussion 89-90]
27. Thomas F.P., Lovelace R.E., Ding X.S., Sadiq S.A., Petty G.W., Sherman W.H., et al. Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy. Muscle Nerve 15 8 (1992) 891-898
28. Ghobrial I.M., Fonseca R., Greipp P.R., Blood E., Rue M., Vesole D.H., et al. Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study. Cancer 101 11 (2004) 2593-2598
29. Silverman G.J., and Weisman S. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 48 6 (2003) 1484-1492
30. McHeyzer-Williams M.G., and Ahmed R. B cell memory and the long-lived plasma cell. Curr Opin Immunol 11 2 (1999) 172-179
31. Treon S.P., Gertz M.A., Dimopoulos M., Anagnostopoulos A., Blade J., Branagan A.R., et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. Blood 107 9 (2006) 3442-3446